Cravatex Ltd

Cravatex has announced its financial results for the quarter ending in 202412, revealing a significant shift in performance during Q3 FY24-25. The company's assessment score has declined, indicating challenges that may require further analysis of the factors influencing this change. Stakeholders are encouraged to monitor the situation closely.

Cravatex, a microcap trading company, has reported its financial results for the second quarter of fiscal year 2024-25. While there has been a significant increase in PBT and PBDIT, there are concerns regarding PAT and Net Sales. The company's efficiency has improved, but reliance on non-business income may not be sustainable.

Cravatex, a microcap trading company, has reported a negative performance in the quarter ending March 2024, with a decline in net sales and profit before tax. While the company has maintained a high level of cash and cash equivalents and a high dividend payout ratio, the negative trends in sales and profit raise concerns about its future performance.

Cravatex, a microcap trading company, reported a flat financial performance for the quarter ended March 2024. However, the half-yearly PAT showed a growth of 107.82% year on year, while Net Sales fell by -39.48%. Non-Operating Income is 893.33% of PBT, indicating a high reliance on non-business activities. MarketsMOJO has given a 'Strong Sell' call for the stock.

Cravatex, a microcap trading company, has received a 'Sell' rating from MarketsMOJO due to its high debt-to-equity ratio and poor long-term growth. Its recent financial results also raise concerns, with low net sales and high non-operating income. The stock is currently trading at a risky level and may be overvalued. However, it has shown improvement in its technical trend and has consistently outperformed the BSE 500 index. Investors should carefully consider these factors before investing in the company.

Cravatex, a microcap trading company, has been performing well in the market, with its stock reaching a 52-week high on February 6th, 2024. The stock has seen a 19.71% increase in the past five days and is currently trading above its moving averages. With a remarkable performance of 57.17% in the past year, Cravatex shows potential for growth in the trading industry.

Cravatex, a microcap trading company, has seen a surge in its stock price, reaching a 52-week high of Rs. 676 on February 5th, 2024. The stock has outperformed the sector by 20.08% and has been on a consecutive gain for the last 4 days, with a 25.07% increase in returns. It is currently trading higher than its moving averages and has shown a strong performance in the past year, outperforming the Sensex. However, this article does not make any recommendations or predictions about its future potential. Investors are advised to do their own research before investing.

Cravatex, a microcap trading company, has reached a 52-week high on January 12th, 2024, with a stock price of Rs.648. The stock has been performing well, outperforming the sector by 3.57% and showing a total increase of 26.93% in the past three days. With positive moving averages and a strong performance in the past year, Cravatex is a company to watch in the trading industry.

Cravatex, a microcap trading company, has reached a 52-week high on January 11th, 2024 with a current stock price of Rs 555. It has outperformed the sector by 2.3% and has been on a consecutive gain for the last 2 days, with a 8.79% increase in returns. The stock is currently rated as 'Hold' by MarketsMOJO and has shown a strong performance in the past year, outperforming the Sensex's performance. Cravatex's recent surge in stock price and positive performance make it a company to watch in the microcap trading sector.

Cravatex, a microcap trading company, has received a 'Hold' rating from MarketsMOJO due to its recent bullish trend and improved technical indicators. However, the company's high debt to equity ratio and poor long-term growth may pose risks for investors. Its latest quarter also saw a decline in net sales and low profitability.

Cravatex, a microcap trading company, reported a 1.50% growth in net sales and a significant increase of 640.48% in consolidated net profit for the quarter ended September 2023. However, operating profit and interest expenses showed declines, and the company's debt-equity ratio has reached its highest level in five half-yearly periods.